Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Interest Expenses (2023 - 2025)

Bioregenx (BRGX) has 3 years of Interest Expenses data on record, last reported at $72106.0 in Q3 2025.

  • For Q3 2025, Interest Expenses rose 6.74% year-over-year to $72106.0; the TTM value through Sep 2025 reached $301187.0, up 19.47%, while the annual FY2024 figure was $290662.0, 51.98% up from the prior year.
  • Interest Expenses reached $72106.0 in Q3 2025 per BRGX's latest filing, up from $71086.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $83756.0 in Q4 2024 and bottomed at $2046.0 in Q3 2023.
  • Average Interest Expenses over 3 years is $54831.8, with a median of $67553.0 recorded in 2024.
  • Peak YoY movement for Interest Expenses: skyrocketed 3201.71% in 2024, then grew 1.67% in 2025.
  • A 3-year view of Interest Expenses shows it stood at $45193.0 in 2023, then surged by 85.33% to $83756.0 in 2024, then decreased by 13.91% to $72106.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $72106.0 in Q3 2025, $71086.0 in Q2 2025, and $74239.0 in Q1 2025.